ABSTRACT Motor and non-motor manifestations are common and disabling features of hereditary spastic paraplegia (HSP). Botulinum toxin type A (Btx-A) is considered effective for spasticity and may impr

Figshare2018-03-01 更新60

Subjective awareness of difficulty turning in bed as evaluated by PDSS-2 item 9 and nocturnal kinetic parameters.

帕金森病睡眠障碍

运动功能评估

Subjective awareness of difficulty turning in bed as evaluated by PDSS-2 item 9 and nocturnal kinetic parameters.

Figshare2017-11-10 更新30

Motor function in SMA type 2 and 3 patients.

脊髓性肌萎缩症

运动功能评估

Motor function in SMA type 2 and 3 patients.

NIAID Data Ecosystem70

X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition. X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition

神经肌肉疾病治疗

组蛋白去乙酰化酶抑制剂

X-linked myotubular myopathy (XLMTM) is a fatal neuromuscular disorder caused by loss of function mutations in MTM1 . At present, there are no directed therapies for XLMTM, and incomplete understandin

NIAID Data Ecosystem50

Motor outcome after surgery or botulinum toxin injection.

资源简介：

相关数据集